Opportunity
SBIR / STTR #DON26BZ06-DV088
Prototype Minimally Invasive Remote Blood Collection Device for Cetaceans (SBIR Phase II)
Buyer
Navy
Posted
September 02, 2026
Respond By
October 21, 2026
Identifier
DON26BZ06-DV088
NAICS
339112, 541715, 541714
This opportunity from the Department of the Navy seeks innovative solutions for marine mammal health monitoring: - Government Buyer: - Department of the Navy, Office of Naval Research (ONR), DON SBIR/STTR Program Management Office - Solicitation for a prototype minimally invasive remote blood collection device for free-ranging cetaceans (including Fleet dolphins) - Device must be waterproof, remotely deployable, and capable of collecting 200-800 uL of capillary blood - Must function with cetaceans having epidermal thickness from less than 2.5 mm to greater than 10 mm - Includes blood collection device, waterproof housing, suction cup tag carrier, and suction cup-based tag attachment - Device size approx. 3.40x2.25x1.30 in, weight 0.85-0.95 oz, with narrow incision capability and protection against seawater intrusion - No specific OEMs or vendors are named; the solicitation is open to small businesses with relevant biomedical device expertise - Notable requirements: - Direct to Phase II SBIR opportunity (no prior Phase I required) - Base period up to 24 months, $1M; option period up to 24 months, $1M (total potential $2M over 48 months) - Option period requires 1:1 cost matching with non-SBIR/STTR funding - Device should be adapted from existing human capillary blood collection technology - Supports Navy mission readiness, marine mammal health monitoring, biosurveillance, and environmental compliance
Description
This solicitation invites proposals for the development of a minimally invasive remote blood collection device for free-ranging cetaceans. The project aims to advance research and conservation efforts related to cetaceans. It is part of the SBIR/STTR program and supports the Navy's research initiatives. The solicitation is a pre-release topic focused on innovative biomedical device development. Questions are accepted until March 7, 2024, and proposals are due by April 17, 2024.